Means Investment CO. Inc. Sells 7,717 Shares of CVS Health Corporation $CVS

Means Investment CO. Inc. cut its position in CVS Health Corporation (NYSE:CVS) by 65.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 4,130 shares of the pharmacy operator’s stock after selling 7,717 shares during the quarter. Means Investment CO. Inc.’s holdings in CVS Health were worth $354,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. M Holdings Securities Inc. acquired a new position in CVS Health in the third quarter valued at about $890,000. Brighton Jones LLC raised its position in shares of CVS Health by 7.5% during the third quarter. Brighton Jones LLC now owns 19,160 shares of the pharmacy operator’s stock worth $1,642,000 after purchasing an additional 1,339 shares during the period. American State Bank Iowa raised its position in shares of CVS Health by 9.5% during the third quarter. American State Bank Iowa now owns 3,834 shares of the pharmacy operator’s stock worth $329,000 after purchasing an additional 333 shares during the period. Cullinan Associates Inc. lifted its holdings in shares of CVS Health by 15.2% during the 3rd quarter. Cullinan Associates Inc. now owns 53,469 shares of the pharmacy operator’s stock valued at $4,582,000 after purchasing an additional 7,045 shares in the last quarter. Finally, Ethic Inc. lifted its holdings in shares of CVS Health by 6.7% during the 3rd quarter. Ethic Inc. now owns 48,352 shares of the pharmacy operator’s stock valued at $4,143,000 after purchasing an additional 3,018 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

Insider Buying and Selling

In other CVS Health news, EVP Prem Shah bought 23,855 shares of CVS Health stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president owned 88,516 shares of the company’s stock, valued at $7,425,607.24. This trade represents a 36.89% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.85% of the company’s stock.

CVS Health Stock Down 0.1%

NYSE:CVS opened at $83.76 on Monday. The stock has a 50-day simple moving average of $90.37 and a 200 day simple moving average of $88.89. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a market cap of $107.17 billion, a PE ratio of 9.75, a PEG ratio of 0.73 and a beta of 0.58. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. During the same quarter in the previous year, the business posted $1.60 EPS. The business’s quarterly revenue was up 5.4% compared to the same quarter last year. On average, sell-side analysts expect that CVS Health Corporation will post 8.25 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is currently 30.97%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CVS. Raymond James Financial set a $103.00 price objective on CVS Health in a research report on Friday. Weiss Ratings downgraded shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of CVS Health in a research note on Friday, October 9th. Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Twenty-two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $108.25.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.